GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Research & Development

Longevity Biomedical (Longevity Biomedical) Research & Development : $ Mil (TTM As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Longevity Biomedical's Research & Development for the six months ended in . 20 was $0.00 Mil. Longevity Biomedical does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.


Longevity Biomedical Research & Development Historical Data

The historical data trend for Longevity Biomedical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Research & Development Chart

Longevity Biomedical Annual Data
Trend
Research & Development

Longevity Biomedical Semi-Annual Data
Research & Development

Longevity Biomedical Research & Development Calculation

This is the expense the company spent on research and development.


Longevity Biomedical  (NAS:LBIO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Longevity Biomedical Research & Development Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Longevity Biomedical (Longevity Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines